Cargando…

Sequential FDG-PET and induction chemotherapy in locally advanced adenocarcinoma of the Oesophago-gastric junction (AEG): The Heidelberg Imaging program in Cancer of the oesophago-gastric junction during Neoadjuvant treatment: HICON trial

BACKGROUND: 18-Fluorodeoxyglucose-PET ((18)F-FDG-PET) can be used for early response assessment in patients with locally advanced adenocarcinomas of the oesophagogastric junction (AEG) undergoing neoadjuvant chemotherapy. It has been recently shown in the MUNICON trials that response-guided treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lorenzen, Sylvie, von Gall, Carl, Stange, Annika, Haag, Georg M, Weitz, Jürgen, Haberkorn, Uwe, Lordick, Florian, Weichert, Wilko, Abel, Ulrich, Debus, Jürgen, Jäger, Dirk, Münter, Marc W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3149600/ https://www.ncbi.nlm.nih.gov/pubmed/21702914 http://dx.doi.org/10.1186/1471-2407-11-266

Ejemplares similares

The pattern of recurrence of adenocarcinoma of the oesophago-gastric junction
por: Wayman, J, et al.
Publicado: (2002)

Neoadjuvant chemotherapy for carcinoma of the oesophagus and oesophago-gastric junction: a six-year experience
por: Halliday, Brian P, et al.
Publicado: (2007)

Immune Checkpoint Inhibition in Oesophago-Gastric Carcinoma
por: Högner, Anica, et al.
Publicado: (2021)

Optimising Multimodality Treatment of Resectable Oesophago-Gastric Adenocarcinoma
por: Suwaidan, Ali Abdulnabi, et al.
Publicado: (2022)

mRNA profiling of the cancer degradome in oesophago–gastric adenocarcinoma
por: Baren, J P, et al.
Publicado: (2012)

ICORG 10-14: NEOadjuvant trial in Adenocarcinoma of the oEsophagus and oesophagoGastric junction International Study (Neo-AEGIS)
por: Reynolds, JV, et al.
Publicado: (2017)

Biomarker analysis of cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric and oesophago-gastric junction cancer: results from a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO)
por: Luber, Birgit, et al.
Publicado: (2011)

Modified Oesophago-Gastric Dissociation (M-OGD) — a technical modification
por: Coletta, Riccardo, et al.
Publicado: (2020)

PET/CT-tailored treatment of locally advanced oesophago-gastric junction adenocarcinoma: a report on the feasibility of the multicenter GastroPET study
por: Obermannova, Radka, et al.
Publicado: (2022)

Propofol Sedation for Oesophago-Gastro-Duodenoscopy
por: Watt, J. M., et al.
Publicado: (1999)

Re-organisation of oesophago-gastric cancer care in England: progress and remaining challenges
por: Palser, Thomas R, et al.
Publicado: (2009)

Molecular effects of Lapatinib in the treatment of HER2 overexpressing oesophago-gastric adenocarcinoma
por: De Silva, Nadeera, et al.
Publicado: (2015)

The Role of Mucin Expression in the Diagnosis of Oesophago-Gastric Cancer: A Systematic Literature Review
por: Patel, Nikhil Manish, et al.
Publicado: (2023)

Double stenting for malignant oesophago-respiratory fistula
por: Włodarczyk, Janusz, et al.
Publicado: (2016)

Laparoscopic resectional oesophago-gastroplasty: a novel technique for minimally invasive treatment of large high gastric lesser curve GIST involving gastroesophageal junction
por: Foo, Mang Yik, et al.
Publicado: (2020)

Psychosocial functioning in individuals with advanced oesophago-gastric cancer: a mixed methods systematic review
por: Ghiglieri, Cara, et al.
Publicado: (2023)

A pooled analysis of molecularly targeted agents for treatment of metastatic oesophago-gastric cancer in elderly patients
por: Lv, Hui, et al.
Publicado: (2020)

ASO Author Reflections: Applications of Artificial Intelligence in Oesophago-Gastric Malignancies—Present Work and Future Directions
por: Chidambaram, Swathikan, et al.
Publicado: (2021)

Evaluating the care received by patients with oesophago-gastric (OG) cancer: the richer picture provided by linked datasets
por: Brand, Christian, et al.
Publicado: (2017)

Feasibility of Implementation and the Impact of a Digital Prehabilitation Service in Patients Undergoing Treatment for Oesophago-Gastric Cancer
por: Moorthy, Krishna, et al.
Publicado: (2023)

The rare case of oesophago-pericardial fistula secondary to pulmonary tuberculosis
por: Sidhu, Kavina Kaur, et al.
Publicado: (2022)

Plasma MIC-1 correlates with systemic inflammation but is not an independent determinant of nutritional status or survival in oesophago-gastric cancer
por: Skipworth, R J E, et al.
Publicado: (2010)

Research protocol for a diagnostic study of non-invasive exhaled breath analysis for the prediction of oesophago-gastric cancer
por: Markar, Sheraz R, et al.
Publicado: (2016)

Volume-outcome revisited: The effect of hospital and surgeon volumes on multiple outcome measures in oesophago-gastric cancer surgery
por: Fischer, Claudia, et al.
Publicado: (2017)

Machine Learning for Risk Prediction of Oesophago-Gastric Cancer in Primary Care: Comparison with Existing Risk-Assessment Tools
por: Briggs, Emma, et al.
Publicado: (2022)

Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: a randomised phase II study
por: Roy, A, et al.
Publicado: (2012)

Evaluating the role of fluorodeoxyglucose positron emission tomography-computed tomography in multi-disciplinary team recommendations for oesophago-gastric cancer
por: Blencowe, N S, et al.
Publicado: (2013)

Re-organisation of oesophago-gastric cancer services in England and Wales: a follow-up assessment of progress and remaining challenges
por: Groene, Oliver, et al.
Publicado: (2014)

Main influencing factors and health-related quality of life issues in patients with oesophago-gastric cancer – as measured by EORTC tools
por: Tomaszewski, Krzysztof A., et al.
Publicado: (2013)

The effect of anti-angiogenic agents on overall survival in metastatic oesophago-gastric cancer: A systematic review and meta-analysis
por: Chan, David L., et al.
Publicado: (2017)

Understanding Potentially Preventable Mortality Following Oesophago-Gastric Cancer Surgery: Analysis of a National Audit of Surgical Mortality
por: Liu, David S., et al.
Publicado: (2023)

The risk of oesophago-gastric cancer in symptomatic patients in primary care: a large case–control study using electronic records
por: Stapley, S, et al.
Publicado: (2013)

Diagnosis and treatment for gastro-oesophageal cancer in England and Wales: analysis of the National Oesophago-Gastric Cancer Audit (NOGCA) database 2012–2020
por: Pucher, Philip H, et al.
Publicado: (2023)

Oesophageal squamous papilloma: a rare finding on oesophago-gastro-duodenoscopy with malignant potential
por: Li, Jia Xi Julian, et al.
Publicado: (2023)

Significance of tumour regression in lymph node metastases of gastric and gastro‐oesophageal junction adenocarcinomas
por: Reim, Daniel, et al.
Publicado: (2020)

1228P Stage migration, changed treatment profile and survival impact in newly diagnosed oesophago-gastric cancer in Scotland during the COVID-19 pandemic: A national study
por: Baxter, M., et al.
Publicado: (2022)

Oesophago-Cutaneous Fistula Due to a Broken Titanium Plate of Anterior Cervical Plate Fixation
por: Kawoosa, N N, et al.
Publicado: (2011)

Value of central review of RECIST v1.1 outcomes in the AGITG INTEGRATE randomised phase 2 international trial for advanced oesophago-gastric cancer
por: Sjoquist, Katrin M., et al.
Publicado: (2022)

A phase II study for metabolic in vivo response monitoring with sequential (18)FDG-PET-CT during treatment with the EGFR-monoclonal-antibody cetuximab in metastatic colorectal cancer: the Heidelberg REMOTUX trial
por: Berger, Anne Katrin, et al.
Publicado: (2012)

Thoracoscopic oesophago-oesophagostomy in the prone position for oesophageal stenosis caused by dilated azygos vein in polysplenia-associated heterotaxy
por: Bhojwani, Rajesh, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7jqq7u8dmvng503r8p1n3hg3np